Figure 3.
Cost-effectiveness acceptability curves of the empagliflozin group compared to the control group for different populations: (A) total population; (B) those with diabetes; (C) those without diabetes. CE, cost-effectiveness.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.